BioSpace News Archive

Policy

Keio Global Research Institute Research: Analyzing the Impact of Japan’s Regenerative Medicine Regulatory Reforms

The researchers also describe measures being introduced by the Ministry of Health, Labor and Welfare to increase transparency and accountability in this sector.

February 2, 2018

·

4 min read

Counsyl Celebrates Anniversary With $80M F

Deals

Hollister to Divest Part of Its Wound Care Biz

The Hollister Wound Care product portfolio includes brands Hydrofera Blue, Endoform, TRIACT, and FastCast, among others.

February 2, 2018

·

1 min read

Biotech Bay

Cerus Announces Closing of Public Offering of Common Stock and Full Exercise of the Underwriter’s Option to Purchase Additional Shares

Cerus today announced the closing of a registered underwritten public offering of its common stock, which included the sale of additional shares of common stock upon full exercise of the underwriter’s option to purchase additional shares.

February 2, 2018

·

3 min read

Business

Innoviva to Report Fourth Quarter Financial Results on February 8 at 5:00 p.m. EDT

Innoviva announced today that it will report financial results for the fourth quarter and year ended December 31, 2017 after market close on February 8, 2017.

February 2, 2018

·

1 min read

Genetown

Akebia Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) With an Exercise Price of $14.78

Akebia granted nine newly-hired employees options to purchase an aggregate of 53,550 shares of Akebia’s common stock on January 31, 2018, as inducements material to each such employee’s entering into employment with Akebia.

February 2, 2018

·

1 min read

Drug Development

Clene Nanomedicine Announces Preclinical Results of A Novel Gold Nanocrystal Remyelinating Treatment for Multiple Sclerosis at ACTRIMS Forum Annual Meeting

Statistically significant improvements in remyelination were demonstrated via quantitation of myelin using immunohistochemistry and transmission electron microscopy.

February 2, 2018

·

3 min read

Dr. Reddy’s Laboratories Announces the Launch of Tetrabenazine Tablets in the U.S. Market

Dr. Reddy’s Laboratories announced today that it has launched Tetrabenazine Tablets, a therapeutic equivalent generic version of Xenazine® (tetrabenazine) in the United States market approved by the U.S. Food and Drug Administration (USFDA).

February 2, 2018

·

3 min read

Business

Portage’s PPL Forms a Joint Venture With University of Glasgow to Develop New Peptide Therapeutics

Portage Pharmaceuticals is providing an undisclosed funding to the new business along with a limited license to its CellPorter peptide delivery technology.

February 2, 2018

·

4 min read

BioMidwest

Respicardia Announces First U.S. Commercial Case With the remedē System

The first case coincides with the naming of seasoned medical device executive, Peter Sommerness, as CEO of Respicardia and leader of the remede System U.S. launch.

February 2, 2018

·

3 min read

Pharm Country

Acorda Fourth Quarter/Year End 2017 Update

Acorda will host a conference call and webcast to report its fourth quarter 2017 financial results and pipeline updates on Thursday, February 15 at 8:30 a.m. ET.

February 2, 2018

·

3 min read